Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kwee, Ingrid L.
and
Nakada, Tsutomu
1988.
Phospholipid profile of the human brain: 31P NMR spectroscopic study.
Magnetic Resonance in Medicine,
Vol. 6,
Issue. 3,
p.
296.
1988.
Prevention by Choline of the Depletion of Membrane Phosphatidylcholine by a Cholinesterase Inhibitor.
New England Journal of Medicine,
Vol. 318,
Issue. 3,
p.
191.
Farooqui, Akhlaq A.
Liss, Leopold
and
Horrocks, Lloyd A.
1988.
Neurochemical aspects of Alzheimer's disease: Involvement of membrane phospholipids.
Metabolic Brain Disease,
Vol. 3,
Issue. 1,
p.
19.
Farooqui, Akhlaq A.
Liss, Leopold
and
Horrocks, Lloyd A.
1988.
Lipid Storage Disorders.
p.
689.
Pettegrew, J. W.
1989.
Biological Markers of Alzheimer’s Disease.
p.
83.
Elble, Rodger
Giacobini, Ezio
and
Higgins, Constance
1989.
Choline levels are increased in cerebrospinal fluid of Alzheimer patients.
Neurobiology of Aging,
Vol. 10,
Issue. 1,
p.
45.
Ulus, Ismail H.
Wurtman, Richard J.
Mauron, Charlotte
and
Blusztajn, Jan Krzysztof
1989.
Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum.
Brain Research,
Vol. 484,
Issue. 1-2,
p.
217.
Khachaturian, Zaven S.
1989.
The role of calcium regulation in brain aging: reexamination of a hypothesis.
Aging Clinical and Experimental Research,
Vol. 1,
Issue. 1,
p.
17.
PETTEGREW, JAY W.
1989.
Molecular Insights into Alzheimer's Disease.
Annals of the New York Academy of Sciences,
Vol. 568,
Issue. 1,
p.
5.
Blusztajn, Jan Krzysztof
Gonzalez-Coviella, Ignacio Lopez
Logue, Mary
Growdon, John H.
and
Wurtman, Richard J.
1990.
Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.
Brain Research,
Vol. 536,
Issue. 1-2,
p.
240.
Wurtman, R. J.
Ulus, I. H.
Blusztajn, J. K.
Coviella, I. Lopez G.
Logue, M.
Mauron, C.
and
Growdon, J. H.
1990.
Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics.
p.
211.
Pettegrew, J. W.
Withers, G.
and
Panchalingam, K.
1990.
NMR: Principles and Applications to Biomedical Research.
p.
204.
Buyukuysal, R. Levent
and
Wurtman, Richard J.
1990.
4‐Aminopyridine Increases Acetylcholine Release Without Diminishing Membrane Phosphatidylcholine.
Journal of Neurochemistry,
Vol. 54,
Issue. 4,
p.
1302.
Ohm, T. G.
Bohl, J.
Steinmetz, H.
and
Lemmer, B.
1990.
Neuropsychopharmacology.
p.
684.
Nakada, Tsutomu
Kwee, Ingrid L.
Suzuki, Nobuyuki
and
Ellis, William G.
1990.
Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases.
Vol. 38A,
Issue. ,
p.
183.
Kish, Stephen J.
Robitaille, Yves
Ball, Melvyn
Gilbert, Joseph
Deck, John H.N.
Chang, Li-Jan
and
Schut, Lawrence
1990.
Glycerophosphoethanolamine concentration is elevated in brain of patients with dominantly inherited olivopontocerebellar atrophy.
Neuroscience Letters,
Vol. 120,
Issue. 2,
p.
209.
Welch, K. M. A.
1990.
NMR: Principles and Applications to Biomedical Research.
p.
429.
Levent Buyukuysal, R.
Holmes, Todd C.
and
Wurtman, Richard J.
1991.
Interactions of 3,4-diaminopyridine and choline in stimulating acetylcholine release and protecting membrane phospholipids.
Brain Research,
Vol. 541,
Issue. 1,
p.
1.
Miller, Bruce L.
Read, Stephen
Tang, Cathy
and
Jenden, Donald
1991.
Differences in red blood cell choline and lipid-bound choline between patients with Alzheimer disease and control subjects.
Neurobiology of Aging,
Vol. 12,
Issue. 1,
p.
61.
Klunk, William E.
McClure, Richard J.
and
Pettegrew, Jay W.
1991.
Possible roles ofl-phosphoserine in the pathogenesis of Alzheimer’s disease.
Molecular and Chemical Neuropathology,
Vol. 15,
Issue. 1,
p.
51.